QC
FENC icon

Quadrature Capital’s Fennec Pharmaceuticals FENC Stock Holding History

Quadrature Capital’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$814K Buy
+75,726
New +$618K 0.01% 809
2026
Q1 		– Sell
-14,761
Closed -$114K – 1549
2025
Q4 		$114K Sell
14,761
-560
-4% -$4.6K ﹤0.01% 1082
2025
Q3 		$144K Buy
+15,321
New +$133K ﹤0.01% 836

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Quadrature Capital's FENC Position: Q2 2026 in Review

Quadrature Capital opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 75,726 shares worth $814K. The stake represents 0.01% of the portfolio and ranks #809 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in FENC as recently as Q4 2025.

Quadrature Capital first reported a position in FENC in Q3 2025 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Quadrature Capital held 75,726 shares of Fennec Pharmaceuticals worth $814K as of Q2 2026.
  • Fennec Pharmaceuticals was a new Quadrature Capital position in Q2 2026.
  • Fennec Pharmaceuticals made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #809 holding.
  • Quadrature Capital first reported a position in Fennec Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.